Dr. Samith Sandadi, MD

Dr. Sandadi practices at Lee Memorial Hospital in Fort Myers, Florida, part of Lee Health System.

Dr. Sandadi's NPI, 1790980142, was assigned on June 17, 2007. Dr. Sandadi graduated from University of Miami, Miller School of Medicine in 2006. Dr. Sandadi holds Florida license ME120588.

Dr. Sandadi's primary practice is Lee Memorial Hospital, at 2776 Cleveland Ave, Fort Myers, FL 33901 in Lee County. The practice phone is (239) 343-5000.

Dr. Sandadi's primary practice is Lee Memorial Hospital in Fort Myers, Florida, part of Lee Health System. Dr. Sandadi is also affiliated with Gulf Coast Medical Center. The medical group on file is Lee Physician Group. Dmand AI also links Dr. Sandadi to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sandadi practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Sandadi's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Sandadi is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Sandadi's licenses on file in 3 states: Florida, New York and Ohio.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Sandadi treats.

CMS data shows 872 Medicare services from Dr. Sandadi across 10 procedure codes in 2024, for 299 Medicare patients. Medicare paid $86,853 for them.

CMS counts 299 Medicare patients who saw Dr. Sandadi in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sandadi's median patient age at 64, with 99% women.

In 2024, Dr. Sandadi wrote 221 Medicare Part D claims for 143 patients. 93% of them were for generic drugs. CMS names the drug for 148 of them, across 5 drugs with 11 or more claims each, at $801 in total drug cost. In 2023, CMS named 153 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sandadi for performance year 2024, reported individually. Dr. Sandadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of removal of the uterus by Dr. Sandadi, more than 98% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Sandadi, published from 2012 to 2018. 2013 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms. Dr. Sandadi has published most often in Gynecol Oncol. Dr. Sandadi's most frequent co-authors are Yukio Sonoda, MD, Dennis S. Chi, MD and Richard R. Barakat, MD.

Dmand AI links Dr. Sandadi to 1 clinical trial. Conditions studied include Endometrial Neoplasms and Uterine Cervical Neoplasms.

CMS Open Payments shows 300 general payments to Dr. Sandadi from 42 drug and device companies from 2016 to 2025. Education make up the largest share, 38% of the total. Intuitive Surgical, Inc. paid the most, $17,097.

Dr. Sandadi graduated from University of Miami, Miller School of Medicine in 2006.

Dr. Sandadi is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.